Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.12.2022Exeltis Slovakia s.r.o. (EET)1560DEndovelle 2 mg tablety (tbl 1x28x2 mg (blis.Al/PVC/PVDC-kalendár.bal.))21.12.2022R
 21.12.2022Teva Czech Industries s.r.o. (TEV-CZ-2)00676CALCIUM CHLORATUM-TEVA (sol por 1x100 ml (fľ.skl.hnedá))10.1.2023R
 21.12.2022Teva Czech Industries s.r.o. (TEV-CZ-2)10185EQUORAL 100 mg (cps mol 50x100 mg (blis.Al/Al))1.2.2023R
 21.12.2022Teva Czech Industries s.r.o. (TEV-CZ-2)94465Stoptussin sirup (sir 1x100 ml (fľ.skl.hnedá + odmerka))25.1.2023R
 21.12.2022Teva Czech Industries s.r.o. (TEV-CZ-2)95520TUSSIN (gto por 1x25 ml (fľ.skl.hnedá))12.1.2023R
 21.12.2022Gedeon Richter Plc. (GDN)71901Lunaldin 400 mikrogramov sublingválne tablety (tbl slg 30x400 µg (blis.OPA/Al/PVC/papier/PE/Al))21.12.2022R
 21.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)30181LEKOKLAR 250 mg filmom obalené tablety (tbl flm 14x250 mg (blis. PVC/PVDC/Al))21.12.2022R
 21.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)30446LEKOKLAR 250 mg/5 ml granulát na perorálnu suspenziu (gru por 1x100 ml (68,3 g gran./57,0 ml vody) (fľ.HDPE))21.12.2022R
 21.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)33218Amoksiklav 2x457 mg/5 ml (plu por 1x35 ml (fľ.skl.jantárová+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))21.12.2022R
 21.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)33219Amoksiklav 2x457 mg/5 ml (plu por 1x70 ml (fľ.skl.jantárová+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))21.12.2022R
 21.12.2022Vipharm S.A. (VIH-PL-1)47803Donesyn 10 mg (tbl flm 98x10 mg (blis.PVC/Al))20.12.2022O
 21.12.2022Teva B.V. (TEV-NL-4)2870BRazagilin ratiopharm 1 mg tablety (tbl 100x1 mg (blis.Al/Al))27.12.2022R
 21.12.2022Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))23.1.2023R
 21.12.2022TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3267BPramipexol Teva Pharma 0,26 mg (tbl plg 30x0,26 mg (blis.OPA/Al/PVC/Al))3.1.2023R
 21.12.2022TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3399AEplerenone Teva 25 mg (tbl flm 30x1x25 mg (blis.PVC/PVDC/Al perf.))7.1.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)